The former Camras Vision, a Durham medical device startup, has changed its name to Alievio “as part of a rebranding effort to further position the company as a leader in innovative glaucoma treatment solutions.
Read More
The $15 million the company hopes to raise will help drive the Camras Shunt through U.S. Food and Drug Administration approval and help either commercialize or sell the business.
Read More
Two dozen bioscience companies that previously received loans from the Biotech Center raised about $115 million in follow-on funding from other sources in the last two quarters.
Read More
Startup Camras Vision, which is developing a device to address glaucoma, has closed on $5.7 million in venture capital funding
Read More
Camras Vision Inc., a Triangle-based ophthalmic medical device company, has raised over $3 million in a private stock offering, reports Emily Brice for North Carolina Business News Wire.
Read More
